Taris
United States · Founded 2008 · $102.8M raised
- Founded
- 2008
- Business Model
- B2B
- Total Funding
- $102.8M
- Last Round
- $25.0M Series BDec 2017
- Rounds
- 5
About
TARIS Biomedical was a specialty pharmaceutical company focused on intravesical drug delivery for bladder conditions, most notably developing the LiRIS device for sustained local therapy. Founded in 2008 and headquartered in Lexington, Massachusetts, the company raised over $120M before being acquired by Johnson & Johnson in December 2019 to advance its bladder cancer treatment pipeline.
Summary
Taris is a Biotech company based in United States, founded in 2008. It has raised $102.8M in total across 5 rounds, most recently a $25.0M Series B round in Dec 2017. Investors include Flagship Ventures, Third Rock Ventures and YongHua Capital.
Sign up to view funding chart
Create a free account to see funding visualizations and detailed round data.
Funding History
Dec 2017
Sign up to see all 5 rounds
Full funding history, per-round amounts, and investor participation.
Investors
Similar Companies
Global contract research organization providing comprehensive drug development and laboratory ser...
Global fertility clinics platform
Biopharmaceutical services company
Specialty pharmaceutical company
Biotech advancing cellular rejuvenation programming to restore cell health and reverse disease.
Global oncology biopharmaceutical company developing and commercializing cancer treatments, now r...